Maarten Ooms – Supervised Work —

Research activity per year

Research output

4 results

2024

Development and preclinical evaluation of 161Tb radiopharmaceuticals for cancer treatment
Cassells, I. & Ooms, M. (Peer reviewer), 24 Jun 2024, KUL - Katholieke Universiteit Leuven. 173 p.
Research output
2022

Development of theranostic somatostatin analogues for the treatment of neuroendocrine tumors
Ahenkorah, S., Ooms, M. (Peer reviewer) & Cardinaels, T. (Peer reviewer), 15 Dec 2022, 178 p.
Research output
2021

Synthesis of DFO*-pPh-NCS: towards a bifunctional ligand for targeted radionuclide therapy
Bonneux, C., Ooms, M. (Peer reviewer) & Burgoyne, A. (Peer reviewer), 30 Jun 2021, KUL - Katholieke Universiteit Leuven. 70 p.
Research output
2020

Targeted ALPHA therapy with single-domain antibody fragments, a novel cancer treatment
Dekempeneer, Y., Ooms, M. (Peer reviewer) & Cardinaels, T. (Peer reviewer), 2 Jun 2020, 218 p.
Research output